| | Patterns of Misinterpretation of Adnexal Masses on CT and MR in an Academic Radiology DepartmentReceived 31 January 2009; accepted 23 February 2009. published online 20 April 2009. Rationale and ObjectivesThe aim of this study was to assess potential quality assurance (QA) issues in the diagnosis and characterization of adnexal masses on pelvic computed tomographic (CT) and magnetic resonance (MR) imaging studies. Materials and MethodsImages from 128 women who had oophorectomies during a 16-month period with CT and/or MR studies within 5 years of surgery (145 CT scans from 103 women and 49 MR studies from 42 women, with 17 having both MR and CT studies) were reviewed by three radiologists who assigned QA scores of 0 (no QA issue), 1 (minor issue with minimal impact on clinical care), or 2 (major issue with potential impact on clinical care). The difficulty of diagnosis was assigned a score of 0 (very difficult diagnosis to make), 1 (difficult but possible to make the diagnosis), or 2 (diagnosis should be made). The incidence of adnexal QA issues was calculated using total CT and MR pelvic examinations performed on women during the interval. ResultsTwenty-nine QA issues were identified in 28 women in 17 of 145 CT studies (11.7%) and 12 of 49 MR examinations (24.5%) in women having adnexal surgery (17 of 11,194 [0.15%] of female pelvic CT studies and 12 of 603 [2.0%] of female pelvic MR studies performed in the time interval). Issues included missed lesions, lesions misidentified as leiomyomas, fat described in the lesion but not seen histologically, postmenopausal status of patient not considered, ultrasound correlation not recommended, and confusion of right and left sides. ConclusionErrors in CT and MR studies regarding the diagnosis and characterization of adnexal masses in a highly enriched population of women undergoing adnexal surgery are common. Knowledge of the types of QA issues found in CT and MR studies of adnexal masses should aid in decreasing future errors. Ultrasound is the primary method for imaging adnexal masses, with magnetic resonance (MR) imaging often used as the secondary modality for further characterization of lesions seen on ultrasound. However, pelvic computed tomographic (CT) and MR studies performed for indications other than adnexal imaging often reveal adnexal pathology. Because adnexal lesions are not necessarily in the region of patients' symptoms, these lesions can be overlooked. In addition, the CT and MR appearance of specific types of adnexal lesions might not be well recognized by general radiologists, and therefore, appropriate follow-up of lesions might not be recommended. Peer review is increasingly used by radiologists to obtain feedback and reduce errors in the interpretation of imaging studies. However, little analysis of data from peer review has been published, including peer review for pelvic imaging. The purpose of our study was to review our institution's quality of reporting and interpretation of adnexal masses seen on pelvic CT and MR studies to identify quality assurance (QA) issues and the degree of potential impact on clinical care. Materials and methods  The study population was identified by searching pathology reports from surgeries performed at Beth Israel Deaconess Medical Center, Boston from January 1, 2004, to May 9, 2005, containing the words “pelvic,” “pelvis,” “uterus,” “ovary/ies,” “tube(s),” “adnexa,” and/or “adnexal.” Patients in whom adnexal masses were reported by pathology were recorded. A total of 418 adnexal masses (from 325 women) with 650 sonographic studies, 145 CT studies, and 49 MR studies were reviewed in chronologic order by a gynecologic imager (DL, with 10 years of gynecologic imaging experience), with knowledge of histories but not of the written reports or histology. This patient population has been previously described with respect to sonographic and histologic findings 1, 2, 3. However, the CT and MR findings have not been previously described. Of these 325 women, 128 women had undergone pelvic CT studies (performed on four-slice, eight-slice, and 16-slice scanners) and MR studies (performed at 1.5 T) within 5 years of surgery, including 17 women undergoing both CT and MR studies. Up to three CT and three MR studies (the most recent studies with respect to surgery) within 5 years preceding surgery were included for each patient. This retrospective study was compliant with the Health Insurance Portability and Accountability Act and approved by our institutional review board, and informed consent was waived. For each study, after the images were reviewed and a differential diagnosis was stated, the written report was then reviewed, and potential QA issues were noted. The imaging differential diagnosis was then correlated with the histologic diagnosis. If the reviewer felt that the histologic diagnosis did not correlate with the imaging appearance, the surgical report was reviewed. This was most important for assessment of endometriomas, peritoneal inclusion cysts, and hemorrhagic cysts that were drained at surgery and for diagnoses of adnexal torsion if necrosis was not evident at the time of histology. For cases with imaging findings that did not correlate with the surgical or pathologic findings, the images were reviewed by a pathologist with expertise in gynecologic imaging who reviewed images of the gross appearance (when available) and the histologic slides. Each case was assigned a QA score of 0 (no QA issue), 1 (minor issue with minimal impact on clinical care), or 2 (major issue with potential impact on clinical care). These were subjective impressions based on information that a radiologist would have had available at the time of report interpretation. Lack of describing a lesion, lack of giving an appropriate diagnosis or differential diagnosis, and lack of appropriate imaging follow-up were all potential reasons for raising a QA issue. After the identification of potential QA cases by the primary reviewer, a second review was performed by two abdominal imagers (IP, JK, with 6 and 10 years of abdominal imaging experience, respectively), who independently reviewed all the potential QA cases found by the primary reviewer, along with prior imaging, and assigned a score to each QA issue using the same scoring method. The secondary reviewers gave each case a difficulty score for the complexity of making the diagnosis on the basis of the imaging available at the time of the imaging examination: 0 (very difficult diagnosis to make), 1 (difficult but possible to make the diagnosis, or 2 (diagnosis should be made). Free-text comments were requested to describe reviewers' thoughts. If at least two of the three reviewers felt that a QA issue was present (a score of 1 or 2), and if both of the secondary reviewers gave difficulty scores of 1 or 2, the case was counted as a QA issue. Indications and findings for the studies identified as having potential QA issues were tabulated. Reasons for the misinterpretation of each study were categorized by the subjective impression of the reviewers as to the likely etiology of the error. To determine the population incidence of QA issues, the number of pelvic CT and MR examinations performed on women during the same time period was assessed. Our institution is an academic medical center, with multiple subspecialists in abdominal imaging reading abdominal CT scans and MR specialists (not necessarily abdominal imagers) reading body MR cases. In addition, some pelvic CT and MR examinations performed for musculoskeletal indications are interpreted by musculoskeletal imagers. The abdominal imagers, MR specialists, and musculoskeletal imagers are not necessarily experts in women's imaging. After data analysis was performed, all QA cases were entered into our online QA database. The results of QA cases were discussed in an abdominal imaging QA section meeting. In addition, the results of the study and images from select cases were discussed at grand rounds for both the obstetrics and gynecology and radiology departments. Results  The primary reviewer identified 30 potential QA issues in 28 women, 18 from CT studies and 12 from MR studies. QA issues were raised by the primary reviewer in 18 of 145 CT studies (12.4%) and 12 of 49 MR studies (24.5%). Two women were counted twice, one with issues raised on two CT studies and one with issues raised on CT and MR studies. In 25 of 30 cases (83%), all three reviewers agreed that QA issues were present, and in 1 of 30 (3%) and 4 of 30 (13%) cases, one or the other secondary reviewer did not feel that a QA issue was present (Table 1). In 15 of 30 cases (50%), the two secondary reviewers each gave difficulty scores of 2, indicating that the diagnosis could have been made easily on the basis of the available images. One case, which received a difficulty score of 0 from both secondary reviewers, involved a malignancy that was reasonably interpreted as a physiologic cyst (Fig 1). This case was not counted in the overall statistics of QA issues. | | |  | Patient | Modality | Indication | Age | Finding as Described in Written Report | QA Issue | QA Details | Median QA Score | Difficulty Scores | Final Diagnosis | Interval Between Imaging and Surgery ∗ |  |
|---|
 | 1 | CT | Von Hippel-Lindau syndrome, renal and pancreatic hemangioma | 55 | 3.8-cm left adnexal cyst, “could be further assessed with pelvic US” | Inadequate follow-up recommendation | This was not a simple cyst on CT: US recommendation should be stronger in a postmenopausal woman with 3.8-cm complex cyst | 1 | 2, 2 | Dermoid | 17 mo |  |  | 2 | CT | Flank/back pain, microscopic hematuria | 58 | 3.3-cm adnexal mass (left in findings, right in impression) | Inadequate description of location | Reversed right and left in impression | 1 | 2, NA | Bilateral hydrosalpinx and paratubal cysts | 1 mo |  |  | 3 | CT | Left lower quadrant pain | 49 | 12-cm simple-appearing adnexal cyst; recommended US or MR | Inadequate follow-up recommendation | MR should not be recommended when US is first-line study to assess internal characteristics of cyst | 1 | 1, 2 | Torsion | 1 mo |  |  | 4 | CT | Right lower quadrant pain | 74 | 4.4-cm ovarian mass with mural calcification; “abnormal appearance of ovary” | No differential diagnosis given | | 1 | 2, 2 | Simple cyst, calcified arterioles | 3 wk |  |  | 5 | CT | Right lower quadrant pain radiating to back | 59 | 1.7-cm low-attenuation focus in ovary | Fat thought to be present on imaging, but no fat at pathology† | | 1 | 2, 2 | Bilateral inclusion cysts and adhesions | 1 mo |  |  | 6 | CT | Left lower quadrant pain and fever | 45 | 16-cm complex cystic structure, likely related to known left hydrosalpinx | Inadequate description of location | Only mentioned left side in bilateral process | 1 | 2, 1 | Bilateral tubo-ovarian abscess with intraovarian cysts and acute and chronic salpingitis | 3 wk |  |  | 7a (first exam) | CT | Left flank pain, hydronephrosis | 39 | 9-cm uterine fibroid, eccentric to right | Lack of correlation to prior studies | New mass since 5 years previously | 2 | 2, 2 | Non-Hodgkin lymphoma | 5 mo |  |  | 7b (second exam) | CT | Left costovertebral angle pain | 39 | 8.1-cm right pelvic mass, unchanged, likely fibroid | Lack of correlation to older studies | Compared to study 3 mo previously (7a) but not older studies | 2 | 2, 1 | Non-Hodgkin lymphoma | 2 mo |  |  | 8 | CT | Right lower quadrant pain, fever, abdominal distension | 42 | Tubular fluid–filled pelvic mass, likely hydrosalpinx, and pelvic free fluid | Lack of clinical correlation | No mention of infection in patient with fever, elevated white blood cell count | 1 | 2, 2 | Bilateral pyosalpinx, (right 10 cm, left 15 cm) | 2 d |  |  | 9a (first exam) | CT | Gluteal pain | 51 | Gluteal abscess vs sarcoma with adjacent fat stranding | Missed lesion | | 2 | 2, 1 | Dermoid (4 cm) | 17 mo |  |  | 9b (second exam) | MR | Left gluteal pain and soft-tissue mass | 51 | Gluteal abscess | Missed lesion | | 2 | 2, 2 | Dermoid (4 cm) | 15 mo |  |  | 10 | CT | Left lower quadrant pain | 55 | 4.5-cm hemorrhagic cyst (right), 3.8-cm simple cyst (left); follow-up as clinically indicated | Inadequate follow-up recommendation | US indicated based on patient age and size of lesion | 2 | 1, 2 | Inclusion cyst (right), endometrioma (left) | 17 mo |  |  | 11 | CT | Lower abdominal pain | 74 | 3.6-cm round dense mass in uterine fundus described as fibroid | Miscategorization | | 2 | 0, 1 | Serous papillary carcinoma | 6 mo |  |  | 12 | CT | Abdominal pain, fever | 48 | 8.7-cm and 4.7-cm bilateral degenerating exophytic fibroids | Miscategorization and lack of mention of nonvisualization of normal ovaries | Lack of visualization of normal ovaries not mentioned in report | 2 | 2, 2 | Bilateral serous papillary carcinoma | 12 d |  |  | 13 | CT | Known gastrointestinal stromal tumor, evaluate for chemotherapy response | 77 | None | Missed lesion | | 2 | 2, 2 | Metastatic gastrointestinal stromal tumor (5 cm) | 14 mo |  |  | 14 | CT | Carcinoid tumor | 35 | “Prominent adnexa” unchanged since 2.5 mo previously | Inadequate follow-up recommendation | US was needed to characterize enlarged ovaries | 2 | 2, 1 | Metastatic carcinoid tumor (9 cm) | 4 mo |  |  | 15 | CT | Breast cancer and liver metastases | 33 | 4.4-cm-thick walled cyst with asymmetric enhancement, suspicious for neoplasm | Inadequate differential diagnosis | Impression did not mention this cyst in patient with breast cancer | 2 | 2, 2 | Serous cystadenoma and paratubal cyst | 2 mo |  |  | 16 | CT | History of lymphoma | 63 | None | Missed lesion | | 2 | 2, 2 | Serous cystadenoma (3.2 cm) | 11 mo |  |  | 17 | MR | Ovarian cyst seen on US at 20-wk gestational age | 34 | 8.5-cm adnexal cyst, loss of signal on out-of-phase T1 and fat-saturated T1 | Fat seen on MR but not at pathology† | | 1 | 2, 0 | Epidermal cyst, no fat present | 4 mo |  |  | 18 | MR | Elevated liver function test results | 51 | None | Missed lesion, lack of comparison to prior studies | Known adnexal cyst not mentioned | 1 | 2, 2 | Serous cystadenoma (4.4 cm) | 7 mo |  |  | 19 | MR | Echogenic renal mass and ovarian cyst | 57 | 1.5-cm right cyst, 2.0-cm left cyst, no nodularity or enhancement | Missed lesion | Solid Brenner tumor not mentioned | 1 | 1, 1 | Serous cystadenoma (right), Brenner tumor (left 2 cm) | 3 mo |  |  | 20 | MR | Back pain, known sacral/retroperitoneal mass | 57 | 4.6-cm necrotic retroperitoneal mass, 1.3-cm endometrial lesion | Missed lesion | Necrotic ovarian mass with 7-mm solid nodule | 1 | 2, 0 | Metastatic endometrial cancer | 2 mo |  |  | 21 | MR | Adnexal cyst seen on US at 7-wk gestational age | 34 | 7.1-cm heterogeneous adnexal mass with small area of fat signal intensity | Fat mentioned on MR but not seen at pathology† | Review of pathology showed a classic mucinous cystadenoma: the dumbbell-shaped lesion had fat outside the cystic components, misinterpreted as being within the cyst | 2 | 2, 2 | Mucinous cystadenoma | 7 mo |  |  | 22 | MR | Cervical cancer staging | 49 | 8-cm adnexal cyst with smooth wall with mild enhancement and thin septation, corpus luteum, or cystadenoma | Inadequate differential diagnosis | | 1 | 2, 2 | Hydrosalpinx, salpingitis | 1 mo |  |  | 23 | MR | Adnexal mass seen on US | 64 | 3.1-cm heterogeneous mass, enhancement similar to myometrium, suggests fibroid | Miscategorization | No fibroid seen at surgery | 2 | 2, 1 | Paratubal cyst | 12 d |  |  | 24 | MR | Adnexal mass, fibroids | 49 | Enlarged cystic ovaries | Inadequate differential diagnosis | No mention of possible neoplasm | 2 | 2, 2 | Bilateral dermoids (right 7 cm, left 6 cm) | 1 mo |  |  | 25 | MR | Enlarged uterus on hysterosalpingogram | 35 | 3.3-cm intramural/submucosal uterine lesion | Miscategorization | Adenomyosis called fibroid | 1 | 1, 1 | Adenomyosis | 5 mo |  |  | 26 | MR | Pelvic/rectal pain | 59 | Bilateral ovarian cysts, no pelvic abnormalities | Inadequate follow-up recommendation | Cysts in a postmenopausal woman should be further characterized by US; report gave no description of size of cysts | 2 | 2, 2 | Peritoneal inclusion cyst (right 5 cm, left 8 cm) | 57 mo |  |  | 27 | MR | Fibroids | 49 | 3.9-cm right lesion with low-signal layering; normal left ovary | Inadequate description of location; inadequate comparison to prior studies | US had shown endometrioma on left | 2 | 2, 1 | Endometrioma (left 4 cm) | 3 mo |  | | | |
| ∗ Interval to surgery rounded to nearest month if >1 month. †Lack of fat confirmed by histopathologic review. |
The categories of QA issues identified included observer error with missed lesions (n = 8, including three malignancies; Figure 2, Figure 3, Figure 4), adnexal lesions misidentified as leiomyomas (n = 6; Figure 5, Figure 6), fat described in the lesion but not seen histologically (n = 3; Fig 7), age or postmenopausal status of the patient not considered in the differential diagnosis or follow-up recommendations (n = 2; Fig 8), correlative ultrasound not recommended (n = 2), confusion of right and left sides (n = 2), and miscellaneous issues (n = 7). One case involved two QA issues, and two issues occurred twice for the same patients in two successive studies, 3 months apart. In one patient, an adnexal cyst was missed in an abdominal MR examination. Upon review of the MR images, the cyst was visible only on a scout view and at the edge of the field of view of a coronal T2-weighted single-shot fast spin-echo acquisition (Fig 2). In another patient, in whom a tailored MR examination for evaluation of the sacral plexus was performed, an adnexal mass was incompletely imaged only on the coronal T2-weighted fast spin-echo images and not detected on the initial interpretation of the study. In another patient, a right ovarian dermoid was missed on both CT and MR examinations tailored for the evaluation of hip pain (Fig 4). During the time interval, women had a total of 11,194 pelvic CT scans and 603 pelvic MR scans performed at our institution, amounting to an overall incidence of QA issues of 0.15% (17 of 11,194) on CT imaging and 2.0% (12 of 603) on MR imaging. Discussion  There have been multiple studies assessing the accuracy of pelvic MR and CT studies in patients with known pelvic masses 4, 5, 6, 7. However, to our knowledge, there has not been a study assessing QA issues in patients who are not necessarily referred for adnexal masses. In a 1997 review, Slanetz et al (8) found that 5% of women undergoing abdominopelvic or pelvic CT scans for indications other than ovarian carcinoma or known or suspected pelvic masses had incidental ovarian masses. This demonstrates that adnexal lesions are common. Ultrasound is typically used to assess adnexal masses because it allows for the assessment of the internal characteristics of adnexal cysts. Although CT imaging can be used to assess for signs of malignancy and frequently can characterize fat and calcifications in dermoids (4), it has the limitation of poor soft-tissue discrimination (9). Therefore, when an indeterminate adnexal lesion is visualized on CT imaging, ultrasound is helpful to better characterize the lesion. In our study, not recommending further imaging evaluation with ultrasound was a frequent issue raised by the reviewers. Our most common QA issue was that of missed adnexal lesions. Two of the missed lesions were dermoid cysts. Dermoids are a common ovarian neoplasm, typically being found in women of reproductive age (10). They are frequently found incidentally on physical examination or during surgery. Although the difficulty of detection of dermoids by sonography has been well documented 10, 11, to our knowledge the incidence of missed dermoids on CT and MR studies has not been described. It is reasonable that dermoids could be missed on cross-sectional imaging, because lesions containing fat can blend into the surrounding pelvic fat. In addition to missed dermoids, we also had three missed malignancies: a Brenner tumor, a metastatic endometrial carcinoma, and a metastatic gastrointestinal stromal tumor. Two of these lesions were small, but the gastrointestinal stromal tumor was 5 cm. This emphasizes that the adnexal regions should be carefully assessed when interpreting cross-sectional pelvic imaging studies. Another common reason for error was CT interpretation of a pelvic mass as a leiomyoma and thus failing to identify ovarian pathology. Leiomyomas typically enlarge the uterus, and thus on CT imaging, the uterus will have an abnormal contour or distortion of the endometrial cavity. An exophytic fibroid usually appears homogeneous, with similar attenuation to the uterus. However, leiomyomas may undergo cystic degeneration, appearing as a low attenuation or heterogenous attenuation uterine mass. Calcification is seen in 10% of leiomyomas on CT imaging (12). Although it is well recognized that a complex adnexal mass can be due to a leiomyoma mimicking adnexal malignancy 13, 14, the presence of a solid adnexal mass on CT imaging in a patient without documented leiomyomas on other imaging modalities (such as ultrasound or MR) should lead to further imaging to confirm the diagnosis. In our series of QA issues, three lesions (on four exams) that were called leiomyomas on CT studies were malignancies, one of which was lymphoma and two of which were papillary serous carcinomas. A third common potential error was the identification of fat within lesions on CT and MR studies that did not contain fat histologically. Classic findings of dermoids on CT imaging include low attenuation of the cyst because of fat and calcifications due to tooth or bone formation. At times, a fluid-fluid or fat-fluid level may be present. On MR, classic signal characteristics of fat are the key to the diagnosis 15, 16, including high signal intensity on T1-weighted images, focal chemical shift artifacts 17, 18, 19, and loss of signal on fat-suppressed T1-weighted images. Fat within voxels can be seen by in-phase and out-of-phase imaging. Our series had three lesions for which fat was felt to be present on imaging that were not dermoids histologically. One of the reasons for this was felt to be a dumbbell-shaped mucinous cystadenoma with interdigitating fat in one case. A diagnosis of epidermoid cyst was rendered on histopathologic analysis in another case. The incidence of epidermoid cysts among surgically resected adnexal masses, thought to represent teratomas, may be as high as 17% (20). Although fat is not a characteristic feature of ovarian epidermoid cysts on pathology or cross-sectional imaging (21), cholesterol is frequently present in the cyst contents of these benign neoplasms (22) and may be responsible for the occasional presence of fat within these lesions on CT and MR imaging (23). It is also possible that small fat-containing foci within the lesions were not sampled by pathology. Adnexal lesions in women aged >50 years constituted 15 of 30 of our QA cases (50%). Because menopausal status is frequently not given as part of the indication for a pelvic CT or MR study, the age of 50 (1 year younger than the average age of menopause in the United States, 51 years 24, 25) is a reasonable guideline to increase suspicion for a lesion when an adnexal cyst is seen. Although adnexal cysts are commonly found in postmenopausal women (26), on CT imaging, the internal characteristics cannot be completely described. Because cysts of any size can harbor malignancy, ultrasound is warranted in these patients to ensure that a benign-appearing cyst on a CT study is thin walled and anechoic on ultrasound (27). We use ultrasound for the initial characterization of adnexal masses that are incompletely characterized on CT imaging because it is low cost and readily available. MR is reserved for the characterization of masses that are incompletely described on ultrasound. An important aspect of generating radiology reports is not just giving a description of the findings but also generating an impression and recommending appropriate follow-up. For example, in the breast, the Breast Imaging Reporting and Data System was developed in 1993 in response to variability in mammography reporting that resulted in ambiguity regarding the characteristics of breast masses, their estimated risk for malignancy, and the appropriate follow-up or intervention (28). Therefore we used the identification of lesions, giving appropriate differential diagnosis, and giving recommendations for appropriate follow-up when grading our QA issues. As described previously, after the completion of our study, we entered each case into our online QA database for formal assessment. We presented our results at an abdominal imaging conference, as well as at two separate grand rounds, one for the obstetrics and gynecology department and one for the radiology department. This allowed for the dissemination of our findings to our practicing radiologists, trainees, and major referrers for gynecologic pathology. Future studies will need to be performed to assess how this intervention affects the interpretation of pelvic imaging studies in the future. An important limitation of our study is that we used an enriched population, which included only patients who had undergone adnexal surgery. This allowed for a reference standard of histology and surgery but did not include all pelvic pathology imaged in the interval in individuals who did not have at least one ovary removed. Thus, this is an underestimation of QA issues, because lesions that did not have surgery were not found in our database search. This also allowed for a high index of suspicion for the primary reviewer to identify potential QA issues. However, use of the secondary reviewers allowed for agreement that QA issues were present in the majority of cases (29 of 30) identified by the primary reviewer. The identification of these errors and agreement among the three reviewers also highlights the value of peer review in potentially minimizing errors such as those identified in this study. A second limitation is that the entire population was screened for QA issues by only the primary reviewer. This reviewer used a high index of suspicion for identifying adnexal lesions but could have missed some lesions that other reviewers would have identified. A third limitation is the inclusion of adnexal lesions that were potentially missed because of incomplete or suboptimal evaluation on MR and CT examinations that used a protocol not tailored for evaluation of the pelvis. This approach, however, reflects clinical practice and illustrates the importance of careful review of all images in a given study, including the visualized portions of the pelvis in abdominal and pelvic MR and CT examinations, for potential incidental adnexal masses. The number of adnexal masses missed on MR examinations of other body parts that partially image the pelvis is unknown, and inclusion of these cases may have artificially increased the overall incidence of QA issues for pelvic MR examinations in our study. Similarly, the detection of adnexal masses may be more challenging in CT examinations depending on the imaging protocol (eg, no oral or intravenous contrast). A fourth limitation is that our CT scanners were four-slice, eight-slice, and 16-slice scanners during the interval of imaging. Because of improvements in the image quality of CT and MR studies in recent years, including more recently operated patients might provide more up to date insight to current clinical practice. In conclusion, errors on CT and MR studies regarding adnexal diagnosis in a highly enriched population of women undergoing adnexal surgery are common. In an academic radiology practice, pelvic CT and MR studies are often read by abdominal radiologists with different levels of expertise in gynecologic imaging. The most common clinically important issues were due to observer error, with missed lesions and lesions misidentified as leiomyomas. In addition, age and postmenopausal status should be considered for patients with adnexal masses. We recommend that presumed fibroids on CT imaging be confirmed with pelvic ultrasound and that care be taken to evaluate the pelvis with knowledge of the patient's menstrual history and age. These cases are presented as examples of QA issues in pelvic CT and MR imaging of adnexal masses to alert radiologists to common issues and decrease future errors. References  1. 1Asch E, Levine D. The spectrum of appearance of endometriosis. J Ultrasound Med. 2007;26:993–1002. 2. 2Asch E, Levine D, Hecht J. Histologic, operative, and imaging correlations of adnexalmasses. J Ultrasound Med. 2008;3:327–342. 3. 3Asch E, Levine D, Mehta TS, Kim Y, Hecht J. Assessing factors that impact the quality of performance and interpretation of sonography of adnexal masses. J Ultrasound Med. 2008;27:721–728. 4. 4Tsili AC, Tsampoulas C, Charisiadi A. Adnexal masses: accuracy of detection and differentiation with multidetector computed tomography. Gynecol Oncol. 2008;110:22–31.
CrossRef
5. 5Scoutt LM, McCarthy SM, Lange R, et al. MR evaluation of clinically suspected adnexal masses. J Comput Assist Tomogr. 1994;18:609–618. MEDLINE |
CrossRef
6. 6Sohaib SA, Sahdev A, Van Trappen P, et al. Characterization of adnexal mass lesions on MR imaging. AJR Am J Roentgenol. 2003;180:1297–1304. 7. 7Kalish GM, Patel MD, Gunn ML, et al. Computed tomographic and magnetic resonance features of gynecologic abnormalities in women presenting with acute or chronic abdominal pain. Ultrasound Q. 2007;23:167–175.
CrossRef
8. 8Slanetz PJ, Hahn PF, Hall DA, et al. The frequency and significance of adnexal lesions incidentally revealed by CT. AJR Am J Roentgenol. 1997;168:647–650. 9. 9Togashi K. Ovarian cancer: the clinical role of US, CT, and MRI. Eur Radiol. 2003;13(suppl):L87–L104.
CrossRef
10. 10Friedman AC, Pyatt RS, Hartman DS, et al. CT of benign cystic teratomas. AJR Am J Roentgenol. 1982;138:659–665. 11. 11Laing FC, Van Dalsem FV, Marks WM, et al. Dermoid cysts of the ovary: their ultrasonographic appearances. Obstet Gynecol. 1981;57:99–104. MEDLINE 12. 12Sandler MA, Silver TM, Karo JJ. Gray-scale ultrasonic features of ovarian teratomas. Radiology. 1979;131:705–709. MEDLINE 13. 13Casillas J, Joseph RC, Guerra JJ. CT appearance of uterine leiomyomas. Radiographics. 1990;10:999–1007. MEDLINE 14. 14Sanders RC, McNeil BJ, Finberg HJ, et al. A prospective study of computed tomography and ultrasound in the detection and staging of pelvic masses. Radiology. 1983;146:439–442. MEDLINE 15. 15Walsh JW, Rosenfeld AT, Jaffe CC, et al. Prospective comparison of ultrasound and computed tomography in the evaluation of gynecologic pelvic masses. AJR Am J Roentgenol. 1978;131:955–960. 16. 16Mawhinney RR, Powell MC, Worthington BS, et al. Magnetic resonance imaging of benign ovarian masses. Br J Radiol. 1988;61:179–186. MEDLINE |
CrossRef
17. 17Togashi K, Nishimura K, Itoh K, et al. Ovarian cystic teratomas: MR imaging. Radiology. 1987;162:669–673. MEDLINE 18. 18Yamashita Y, Hatanaka Y, Torashima M, et al. Mature cystic teratomas of the ovary without fat in the cystic cavity: MR features in 12 cases. AJR Am J Roentgenol. 1994;163:613–616. 19. 19Smith RC, Lange RC, McCarthy SM. Chemical shift artifact: dependence on shape and orientation of the lipid-water interface. Radiology. 1991;181:225–229. MEDLINE 20. 20Chatzistamou I, Kairi-Vasillatou E, Hasiakos D, et al. Retrospective study of teratomas of the ovary reveals a high incidence of epidermoid cysts. Gynecol Oncol. 2006;101:548–549. MEDLINE |
CrossRef
21. 21Shinya T, Joja I, Hashimura S, et al. Magnetic resonance imaging features of epidermoid cyst of the ovaries: magnetic resonance and computed tomography findings. J Comput Assist Tomogr. 2006;30:906–909. MEDLINE |
CrossRef
22. 22Takeshita M, Kubo O, Hiyama H, et al. Magnetic resonance imaging and quantitative analysis of contents of epidermoid and dermoid cysts. Neurol Med Chir (Tokyo). 1994;34:436–439. MEDLINE |
CrossRef
23. 23Allbery SM, Chaljub G, Cho NL, Rassekh CH, John SD, Guinto FC. MR imaging of nasal masses. Radiographics. 1995;15:1311–1327. MEDLINE 24. 24McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas. 1992;14:103–115. Abstract |
Full-Text PDF (1049 KB)
|
CrossRef
25. 25McKinlay SM, Bifano NL, McKinlay JB. Smoking and age at menopause in women. Ann Intern Med. 1985;103:350–356. MEDLINE 26. 26Levine D. What is the significance of the incidental discovery of a unilocular ovarian cyst in a postmenopausal woman (either with or without a family history of ovarian cancer) during a pelvic sonographic examination to exclude ovarian carcinoma?. AJR Am J Roentgenol. 1994;163:215–216. 27. 27Patel MD, Dubinsky TJ. Reimaging the female pelvis with ultrasound after CT: general principles. Ultrasound Q. 2007;23:177–187.
CrossRef
28. 28Orel SG, Kay N, Reynolds C, Sullivan DC. BI-RADS categorization as a predictor of malignancy. Radiology. 1999;211:845–850. MEDLINE Harvard Medical School, Boston, MA; and the Departments of Radiology (D.L., I.P., J.K.) and Pathology (J.L.H.), Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215 Address correspondence to: D.L.
This study was supported by grants from the CRICO Risk Management Foundation (Cambridge, MA) and Harvard Medical School PASTEUR and Office of Enrichment Programs (Boston, MA) PII: S1076-6332(09)00147-0 doi:10.1016/j.acra.2009.02.016 © 2009 AUR. Published by Elsevier Inc. All rights reserved. | |
|